Yes, and I just saw the CEO on CNBC this afternoon(Cramer's Mad Money of course!)
Allergan made it big with Botox and has found other lines to complement it, like the eyelash crap and it is selling pretty well. Maybe they wanna pick up Clinuvel?
Would be a nice fit and down the track, a nice distribution/licensing partner....
- Forums
- ASX - By Stock
- CUV
- who can afford afamelanotide?
who can afford afamelanotide?, page-9
-
-
- There are more pages in this discussion • 6 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add CUV (ASX) to my watchlist
|
|||||
Last
$13.50 |
Change
0.130(0.97%) |
Mkt cap ! $676.0M |
Open | High | Low | Value | Volume |
$13.51 | $13.62 | $13.30 | $1.017M | 75.89K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 271 | $13.42 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$13.50 | 886 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 271 | 13.420 |
3 | 667 | 13.390 |
1 | 271 | 13.370 |
1 | 175 | 13.360 |
2 | 306 | 13.350 |
Price($) | Vol. | No. |
---|---|---|
13.500 | 886 | 1 |
13.530 | 2708 | 2 |
13.540 | 702 | 1 |
13.550 | 271 | 1 |
13.570 | 271 | 1 |
Last trade - 16.10pm 26/08/2024 (20 minute delay) ? |
Featured News
CUV (ASX) Chart |